Replies to post #382937 on Amarin Corp Plc (AMRN)

[zmanindc]

They should just meet with the FDA and agree on trial design for the once a day and combo. When approved just retire V 1.0 and screw generics in the US. When the patent runs out in ROW introduce the once a day or combo. I would prefer they get the new version of V approved and then sell the company.